Abstract
A multi-scale parameterization approach, factor analysis scales of generalized amino acid information combined with auto cross covariance, was used to develop quantitative sequence-activity models of peptides using support vector machines. The results demonstrated that this approach could well characterize sequence features of the peptides studied.
Keywords: Factor analysis scales of generalized amino acid information (FASGAI), auto cross covariance (ACC), FASGAI-ACC, quantitative sequence-activity model (QSAM), support vector machines (SVM)
Protein & Peptide Letters
Title: A Multi-Scale Parameterization Approach of Peptides for Quantitative Sequence-Activity Models
Volume: 17 Issue: 5
Author(s): Weihuan Niu, Qingyou Xia and Guizhao Liang
Affiliation:
Keywords: Factor analysis scales of generalized amino acid information (FASGAI), auto cross covariance (ACC), FASGAI-ACC, quantitative sequence-activity model (QSAM), support vector machines (SVM)
Abstract: A multi-scale parameterization approach, factor analysis scales of generalized amino acid information combined with auto cross covariance, was used to develop quantitative sequence-activity models of peptides using support vector machines. The results demonstrated that this approach could well characterize sequence features of the peptides studied.
Export Options
About this article
Cite this article as:
Niu Weihuan, Xia Qingyou and Liang Guizhao, A Multi-Scale Parameterization Approach of Peptides for Quantitative Sequence-Activity Models, Protein & Peptide Letters 2010; 17 (5) . https://dx.doi.org/10.2174/092986610791112738
DOI https://dx.doi.org/10.2174/092986610791112738 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Safe Use of Sodium Dodecyl Sulfate (SDS) to Deactivate SARS-CoV-2: An Evidence-Based Systematic Review
Coronaviruses Maternal SARS-CoV-2 Infection, its Vertical Transmission, and Impact on Overall Perinatal Outcomes: A Narrative Review
Current Pediatric Reviews The Binding of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase May Pave The Way Towards the Design of Potential Drugs for COVID-19 Treatment
Current Pharmaceutical Biotechnology Protein-Ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2
Current Medicinal Chemistry Prevention of COVID-19 Infection in the Medical Population: Possible Help from Anosmia?
Reviews on Recent Clinical Trials Covid-19 Susceptibility and Severity Might be Modified by Vitamin D Status: Theoretical and Practical Considerations
Current Respiratory Medicine Reviews Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery
Current Topics in Medicinal Chemistry A Review on the New Indication of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in the Treatment of Coronavirus Disease 2019
Infectious Disorders - Drug Targets Emerging Roles of Cysteine Cathepsins in Disease and their Potential as Drug Targets
Current Pharmaceutical Design Transmission, Prevention and Therapeutic Strategies for COVID-19: Updates and Challenges
Coronaviruses Molecular Cloning, Sequence and Structural Analysis of Dehairing Mn2+ Dependent Alkaline Serine Protease (MASPT) of Bacillus pumilus TMS55
Protein & Peptide Letters Using Cheminformatics for the Identification of Biological Functions of Small Molecules in Metabolic Pathway
Current Topics in Medicinal Chemistry Coronavirus Disease 2019: Virology and Drug Targets
Infectious Disorders - Drug Targets Novel Coronavirus (COVID-19) Outbreak: Hope and Search for Effective Therapeutic Agent
Letters in Drug Design & Discovery ACE2 as a Potential Target for Management of Novel Coronavirus (nCoV- 2019)
Current Drug Discovery Technologies The Challenges of Biomedical Waste Management During the Ongoing Coronavirus Disease-19 (COVID-19) Pandemic: The Current Scenario
Micro and Nanosystems Natural Compounds as Heme Oxygenase-1 Inducers to Reduce the Deleterious Consequences Following SARS-CoV-2 Infection
Current Chemical Biology Neurological Manifestations of COVID-19 and the Importance of Magnetic Resonance Imaging
CNS & Neurological Disorders - Drug Targets Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials
Mini-Reviews in Medicinal Chemistry Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance
Current Drug Targets